Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
The stock's yield is more than six times the S&P 500 average.
Why it matters
Attributed market update with source link for portfolio context.
Attributed news only. Not investment advice.